The global defibrillator market size is expected to reach USD 13.54 Billion by 2028, at a CAGR of 3.4% over the forecast period, according to the current analysis of Reports and Data.
The global defibrillator market size is expected to reach USD 13.54 Billion by 2028, at a CAGR of 3.4% over the forecast period, according to the current analysis of Reports and Data. Major factors driving defibrillator market revenue growth are massive investments by private players, technological progressions and increase in the occurrence of cardiac disorders due to change in lifestyle.
Access Free sample PDF Copy of the Report @ https://www.reportsanddata.com/sample-enquiry-form/1785
A defibrillator is a machine that delivers a high-energy electric shock to a person who is experiencing cardiac arrest. In emergency medicine, defibrillation is used to stop ventricular fibrillation or pulseless ventricular tachycardia. External, transvenous, and implanted defibrillators are available in the global defibrillator market, depending on the type of device used or required. Arrhythmias, or irregular cardiac rhythms, are detected by each type of device. Furthermore, one of the primary drivers of the defibrillator market is the rising occurrence of cardiac arrests and other cardiovascular problems, particularly irregular heartbeats. Various cardiology and medical organizations have imposed sanctions on the use of automated external defibrillators in public locations, resulting in a rapid increase in the adoption rate in industrialized countries. This trend is expected to continue throughout the projected period, presenting fantastic potential for competitors in the global defibrillator market.
Patients are likely to adopt wearable cardioverter defibrillators as a temporary alternative or to bridge to a long-term implantable cardioverter defibrillator installation as the demand for wearable cardioverter defibrillators grows.
Further key findings from the report suggest
-
- A defibrillator is used to improve the chances of survival by stopping or reducing these abrupt and premature deaths. Heart disease claims the lives of nearly 350,000 Americans each year. The majority of these deaths are caused by a phenomenon known as sudden cardiac arrest, which occurs with little or no warning.
- Defibrillators are extremely important in preventing such life-threatening situations. It is estimated that each minute of delayed defibrillation diminishes the odds of survival by 10%.
- In the defibrillator market, the implantable cardioverter defibrillator had the largest market share of around 51.1 percent. The range of these devices has widened as additional technologies, such as pacemakers, have been integrated with defibrillators.
- North America’s high degree of technology developments and research helped the region to hold the greatest share in 2020, boosting the global defibrillator market growth.
- Outside of a medical setting, the survival rate is only about 1% to 5%, but the chances of survival increase dramatically if they can be treated with an AED right away.
- Because implantable defibrillators are generally available in hospitals, hospitals have made a significant contribution to the rise of implantable and external defibrillators. As a result, hospitals made up the majority of the defibrillator market.
Competitive Landscape:
The global market comprises various market players operating at regional and global levels. These key players are adopting various strategies such as R&D investments, license agreements, partnerships, mergers and acquisitions, collaborations, and joint ventures to gain a robust footing in the market.
Top Companies Profiled in the Report:
Medtronic, Jude Medical LLC, Boston Scientific Corporation, LivaNova, Koninklijke Philips, ZOLL Medical Corporation, Cardiac Science, Physio-Control, Nihon Kohden Corporation, Defibtech, HeartSine Technologies, Progetti Srl, Fukuda Denshi Co, and Schiller AG
To know more about the report, visit @ https://www.reportsanddata.com/report-detail/defibrillator-market
Defibrillator Market Segmentation:
Type Outlook (Revenue, USD Million; 2018 – 2028)
- Implantable Cardioverter Defibrillator
- S-ICD
- T-ICD
- CRT-D
- Single Chamber
- Dual Chamber
- External Defibrillator (ED)
- Manual
- Automated
- Wearable Cardioverter Defibrillator
End Use Outlook (Revenue in USD Million; 2018 – 2028)
- Hospital
- Prehospital
- Public Access Market
- Alternate Care Market
- Home Healthcare
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Ask for Customized Research Report @ https://www.reportsanddata.com/request-customization-form/1785
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Explore Latest Trending Research Reports By Reports and Data:
Minimally Invasive Surgical Instruments Market By Type (Handheld Instruments), By Sales Channel (Online, Stores), By Type of Procedure (Robotic, Non-robotic), By Application (Cardiovascular, Cosmetic), By End-Users (Hospitals, ASC) And Segment Forecasts, 2020-2028
Point of Care Molecular Diagnostics Market Analysis, By Product And Services (Assay Kits, Software, And Services), By Technology (PCR, IN-Situ Hybridization), By Application (Oncology), By End Use (Decentralized Labs, Hospitals), And Forecasts To 2028
Palliative Care Market By Care Type (Hospital Inpatient Care, Private Resident Care, Hospice Resident Care, Nursery and Residential Facility Care, Others), By Application (Cancer, Chronic obstructive pulmonary disease (COPD), Cardiac diseases, Alzheimer’s, Parkinson’s, Kidney failure, Amyotrophic Lateral Sclerosis (ALS), Others), By End-Use (Hospital, Palliative Care centers, Home Care Settings, Long-term Care Centers & Rehabilitation Centers) And By Region, Forecast To 2028
Pelvic Organ Prolapse Repair Market Size, Share And Industry Analysis By Treatment Type (Surgical, Non-surgical), By Application (Cystocele, Uterine Prolapse, Rectocele, Enterocele, Others), By End-user (Hospital, Ambulatory Surgical Centers, Clinic, Other) And Region, Segment Forecasts To 2028
Peripheral Intravenous Catheters Market By Type (Short Peripheral IV Catheter and Integrated/Closed Peripheral IV Catheter), By Technology, By Application (Renal Disease, Oncology, Pediatric Disease, Gastroenterology, Infectious Disease), And By End Users, Forecast To 2020-2028
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problem provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs